(Q34451949)

2 August 2017

1 reference

title

Anticytokine gene therapy of autoimmune diseases (English)

1 reference

2 August 2017

0 references

Prud'homme GJ

1

1 reference

2 August 2017

Lawson BR

series ordinal

2

1 reference

2 August 2017

Theofilopoulos AN

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

Expert Opinion on Biological Therapy

2 August 2017

1 reference

2 August 2017

1

1 reference

2 August 2017

3

1 reference

2 August 2017

359-373

1 reference

The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases

2 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Progress with retroviral gene vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Viral vectors for gene transfer: a review of their use in the treatment of human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Gene vectors for cytokine expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Development and application of adenoviral vectors for gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Gene transfer by biolistic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Improved cationic lipid formulations for in vivo gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

An improved plasmid DNA expression vector for direct injection into skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgG1 or IL-4/IgG1 chimeric proteins protects from autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Prevention of experimental allergic encephalomyelitis by intramuscular gene transfer with cytokine-encoding plasmid vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

High-efficiency gene transfer into skeletal muscle mediated by electric pulses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Electropermeabilization of skeletal muscle enhances gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Theory and in vivo application of electroporative gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Gene transfer to intact mesenteric arteries by electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Direct gene transfer into rat liver cells by in vivo electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Fundamentals of electroporative delivery of drugs and genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Immune modulation by IL-10 gene transfer via viral vector and plasmid DNA: implication for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Direct immunologic activities of CpG DNA and implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Manipulation of TGF-beta to control autoimmune and chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Blockade of TGF-beta by in vivo gene transfer of a soluble TGF-beta type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Encapsulation in hollow fibres of xenogeneic cells engineered to secrete IL-4 or IL-13 ameliorates murine collagen-induced arthritis (CIA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Activity and safety of DNA plasmids encoding IL-4 and IFN gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

DNA-liposome versus adenoviral mediated gene transfer of transforming growth factor beta1 in vascularized cardiac allografts: differential sensitivity of CD4+ and CD8+ T cells to transforming growth factor beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Gene therapy in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Gene therapy for autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

Myoblast-mediated gene transfer to the joint

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.359

21 January 2018

Identifiers

DOI

10.1517/14712598.1.3.359

1 reference

2 August 2017

1 reference